Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

LncRNA and mRNA expression profiles of 3 prostate cancer tumor tissues and 3 normal prostate tissues

ABSTRACT: LncRNA and mRNA expression profiles of 3 prostate cancer tumor samples and 3 normal prostate samples were measured by microarray

ORGANISM(S): Homo sapiens

PROVIDER: GSE73397 | GEO | 2017/06/12

SECONDARY ACCESSION(S): PRJNA296881

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

gene profiles in prostate cancer and normal prostate tissues

Project description:Prostate cancer is one of the most commonly diagnosed cancers among men in the world and the pathogenesis of prostate cancer remains poorly understood. In this study, we intended to disclose genes that might be involved in tumorigenesis using cDNA microarray technology. Keywords: disease state analysis A total of 28 experiments were performed without replicates, using a pool of unrelated fetal tissues as common references. 25 experiments were done for prostate cancer versus common reference and 3 for normal prostate versus common reference. Prostate cancer and normal prostate samples were labeled with Cy5-dUTP. Common references were labeled with Cy3-dUTP.

2008-09-25 | E-GEOD-5957 | biostudies-arrayexpress

Epigenetic analysis of normal prostate tissue and prostate adenocarcinoma

Project description:Genome-wide DNA methylation profiles were obtained from prostate adenocarcinoma samples (20) and corresponding cancer-unrelated normal prostate tissue (28) using Illumina HumanMethylation450 BeadChips. Approximately 485000 CpG sites were measured in every sample.

2015-10-15 | GSE74013 | GEO

gene profiles in prostate cancer and normal prostate tissues

2008-09-26 | GSE5957 | GEO

Aberrant lncRNA expression profiles in OSCC tissues compared with paired normal oral mucosa

Project description:Hypoxic microenvironment plays important roles in the progression of solid tumors including oral squamous cell carcinoma (OSCC). Long noncoding RNAs (lncRNAs) have gained much attention in the past few years. However, it is not clear whether lncRNAs could regulate hypoxia-adaptation of OSCC, and which lncRNAs participate in this process. Using an lncRNA microarray, we analyzed the aberrant lncRNA expression profiles in OSCC tissues compared with paired normal oral mucosa as well as in hypoxic OSCC cells compared with normoxic OSCC cells. Our data revealed 2053 differentially expressed (Fold Change >= 2.0, P-value <= 0.05) lncRNAs, among which 934 lncRNAs were significantly up-regulated and 1119 lncRNAs were down-regulated in OSCC compared with paired normal mucosa. Six OSCC tissues and paired normal oral mucosa were obtained from 6 patients with OSCC. LncRNA expression profiles were evaluated by an Agilent Human LncRNA Array v3.0 (8 x 60K, Arraystar).

2016-07-26 | E-GEOD-84805 | biostudies-arrayexpress

Long noncoding RNA (lncRNA) expression profiles in colorectal cancer tissues and paired adjacent normal tissues

Project description:Long noncoding RNAs (lncRNAs) play important roles in the tumorigenesis and metastasis of colorectal cancer (CRC). This study used a lncRNA microarray to analyze the aberrant lncRNA expression profiles in CRC tissues compared with paired adjacent normal tissues as well as CRC with regional lymph nodes metastasis compared with CRC without regional lymph nodes metastasis.

2020-05-12 | GSE84983 | GEO

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

Project description:Long noncoding RNAs (lncRNAs) have recently been associated with the development and progression of a variety of human cancers. However, to date, the interplay between known oncogenic or tumor suppressive events and lncRNAs has not been well described. Here the novel lncRNA, Prostate Cancer-Associated Transcript 29 (PCAT29), is characterized along with its relationship to the androgen receptor (AR). PCAT29 is suppressed by dihydrotestosterone (DHT) and up-regulated upon castration therapy in a prostate cancer xenograft model. PCAT29 knockdown significantly increased proliferation and migration of prostate cancer cells, while PCAT29 overexpression conferred the opposite effect and suppressed growth and metastases of prostate tumors in chick chorioallantoic membrane (CAM) assays. Finally, in prostate cancer patient specimens, low PCAT29 expression correlated with poor prognostic outcomes. Taken together, these data expose PCAT29 as an androgen regulated tumor suppressor in prostate cancer PCAT29 was knockdown using shRNA in two prostate cancer cell lines VCaP and LNCaP.

2014-07-01 | E-GEOD-58397 | biostudies-arrayexpress

lncRNA-miRNA-mRNA expression profiles in esophageal squamous carcinoma tissues and adjacent normal tissues

Project description:lncRNA-miRNA-mRNA expression profiles in esophageal squamous carcinoma tissues and adjacent normal tissues

| PRJNA380602 | ENA

Expression profile of localized primary prostate cancer samples and the matched normal tissues

Project description:To identify new oncogenic drivers in prostate cancer, we performed transcriptome analysis of localized primary prostate cancer samples and the matched normal tissues.

2021-05-01 | GSE114740 | GEO

Epigenome analysis of normal and cancer tissues in prostate cancer

Project description:Genome wide DNA methylation profiling of normal and cancer tissue samples in prostate cancer. The Illumina Infinium 27k Human DNA methylation Beadchip v1.2 was used to obtain DNA methylation profiles across approximately 27,000 CpGs. Samples are pool of 12 normal and 12 cancer tissues.

2011-03-01 | GSE26319 | GEO

Discovery of lncRNA biomarkers of prostate cancer

Project description:Discovery of lncRNA biomarkers of prostate cancer

| PRJNA474912 | ENA